Serial #98811671
LIVE

Serial Number

98811671

Owner

Ionis Pharmaceuticals, Inc.

Attorney

Brian Focarino

First Use Date

Dec 30, 2024

Filing Date

Oct 21, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #98811671 Trademark

Serial Number: 98811671 • Registration: 8156194

Serial #98811671 is a trademark filed by Ionis Pharmaceuticals, Inc. on October 21, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Ionis Pharmaceuticals, Inc. (8 trademarks)

2855 Gazelle Court
Carlsbad, CA 92010

Entity Type: 03

Trademark Details

Filing Date

October 21, 2024

Registration Date

March 3, 2026

First Use Anywhere

December 30, 2024

First Use in Commerce

December 30, 2024

Published for Opposition

December 2, 2025

Goods & Services

Pharmaceuticals for treatment of genetic diseases and disorders; pharmaceuticals for treatment of cardiovascular, metabolic, neurological, and inflammatory diseases and disorders

Education and medical training services, namely, providing seminars, non-downloadable webinars, and workshops for healthcare professionals, caregivers, patients, and providers in the field of genetic diseases and disorders; online journals, namely, blogs featuring information on genetic diseases and disorders; education and medical training services, namely, providing seminars, non-downloadable webinars, and workshops for healthcare professionals, caregivers, patients, and providers in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; online journals, namely, blogs featuring information on diseases and disorders of the cardiovascular, metabolic, neurological and inflammatory diseases and disorders

Medical services; medical information services; providing a website featuring medical and healthcare information for healthcare professionals, caregivers, patients, and providers in the field of genetic diseases and disorders; medical consulting services in the field of genetic diseases and disorders; healthcare services, namely, providing an online database of medical and healthcare information in the field of genetic diseases and disorders, and collecting data and information on genetic diseases and disorders for treatment and diagnostic purposes; providing medical and healthcare information concerning the screening, diagnosis, and treatment of genetic diseases and disorders; providing a website featuring medical and healthcare information for healthcare professionals, caregivers, patients, and providers in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; medical consulting services in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; healthcare services, namely, providing an online database of medical and healthcare information in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders, and collecting data and information on cardiovascular, metabolic, neurological and inflammatory diseases and disorders for treatment and diagnostic purposes; providing medical and healthcare information concerning the screening, diagnosis, and treatment of cardiovascular, metabolic, neurological and inflammatory diseases and disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 3, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 3, 2026 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Feb 11, 2026 ETOP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 3, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 3, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 3, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 3, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 3, 2026 COAR
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 22, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 2, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 2, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 26, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 3, 2025 CNSA
USE AMENDMENT ACCEPTED
Nov 3, 2025 IUAA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 6, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 6, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 4, 2025 GNFN
FINAL REFUSAL E-MAILED
Sep 4, 2025 GNFR
FINAL REFUSAL WRITTEN
Sep 4, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 28, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 28, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 28, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 15, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 15, 2025 XELR
DATA MODIFICATION COMPLETED
May 6, 2025 DMCC
ASSIGNED TO LIE
May 6, 2025 ALIE
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 23, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 23, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 23, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 23, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 22, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2025 NWOS
AMENDMENT TO USE PROCESSING COMPLETE
Feb 5, 2025 AUPC
USE AMENDMENT FILED
Feb 5, 2025 IUAF
TEAS AMENDMENT OF USE RECEIVED
Feb 5, 2025 EAAU
NEW APPLICATION ENTERED
Oct 21, 2024 NWAP